Characterization of viridans group streptococci from endophthalmitis

眼内炎草绿色链球菌的特征

基本信息

  • 批准号:
    10245289
  • 负责人:
  • 金额:
    $ 22.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The viridans streptococci are classically considered oral commensals with cariogenic potential; however, these bacteria are also listed among the most common species that cause bacterial endophthalmitis. Exogenous bacterial endophthalmitis can occur following trauma, ocular surgery, or ocular injections. Antibiotics are used to treat this disease, however, antibiotics are only able to kill the bacteria and do not ameliorate the damage to the eye. Streptococcal species in particular are associated with very poor visual outcomes; despite treatment, evisceration or enucleation commonly occur. The immediate objective of this application is to characterize endophthalmitis strains of the viridans streptococci and identify their virulence factors. This objective is intended to initiate study into the broader, long-term objectives of determining the mechanisms of pathogenesis of this important group of species and identify potential targets for future therapies. Two major aims are proposed: 1) to investigate the role of bacterial protease HtrA in endophthalmitis and determine its vitreous and bacterial protein substrates, and 2) to analyze the pangenome and virulence transcriptome of endophthalmitis- causing strains. The first aim will be tested by function analysis of recombinant HtrA variants cloned from the viridans strains and by deletion mutagenesis of htrA from htrA-positive strains, as well as genetic addition of htrA to htrA-negative strains. The second aim will employ whole genome sequencing of 21 strains followed by bioinformatics pangenome analysis to identify conserved genes across the collection, and RNA-seq in vivo and in vitro to determine the virulence transcriptome of this group of species. Accomplishment of these aims will springboard the identification of key factors involved in ocular infection by these species. This research is expected to benefit patient ocular health in the long-term because the knowledge to be gained can aid future therapeutic development.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY E MARQUART其他文献

MARY E MARQUART的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY E MARQUART', 18)}}的其他基金

Characterization of viridans group streptococci from endophthalmitis
眼内炎草绿色链球菌的特征
  • 批准号:
    10057004
  • 财政年份:
    2020
  • 资助金额:
    $ 22.55万
  • 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
  • 批准号:
    7494191
  • 财政年份:
    2007
  • 资助金额:
    $ 22.55万
  • 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
  • 批准号:
    7351809
  • 财政年份:
    2007
  • 资助金额:
    $ 22.55万
  • 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
  • 批准号:
    7777295
  • 财政年份:
    2007
  • 资助金额:
    $ 22.55万
  • 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
  • 批准号:
    7583883
  • 财政年份:
    2007
  • 资助金额:
    $ 22.55万
  • 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
  • 批准号:
    7210967
  • 财政年份:
    2007
  • 资助金额:
    $ 22.55万
  • 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
  • 批准号:
    8035361
  • 财政年份:
    2007
  • 资助金额:
    $ 22.55万
  • 项目类别:
Pseudomonas proteases as ocular virulence factors
假单胞菌蛋白酶作为眼部毒力因子
  • 批准号:
    6525059
  • 财政年份:
    2002
  • 资助金额:
    $ 22.55万
  • 项目类别:
Pseudomonas proteases as ocular virulence factors
假单胞菌蛋白酶作为眼部毒力因子
  • 批准号:
    6404863
  • 财政年份:
    2001
  • 资助金额:
    $ 22.55万
  • 项目类别:
DETECTION OF HSV1 DNA IN TEARS--PROOF OF REACTIVATION
眼泪中 HSV1 DNA 的检测——重新激活的证据
  • 批准号:
    6012684
  • 财政年份:
    1999
  • 资助金额:
    $ 22.55万
  • 项目类别:

相似海外基金

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.55万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.55万
  • 项目类别:
    Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
  • 批准号:
    DP230102150
  • 财政年份:
    2023
  • 资助金额:
    $ 22.55万
  • 项目类别:
    Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
  • 批准号:
    468567
  • 财政年份:
    2022
  • 资助金额:
    $ 22.55万
  • 项目类别:
    Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 22.55万
  • 项目类别:
    Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10708102
  • 财政年份:
    2022
  • 资助金额:
    $ 22.55万
  • 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10587015
  • 财政年份:
    2022
  • 资助金额:
    $ 22.55万
  • 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10581945
  • 财政年份:
    2021
  • 资助金额:
    $ 22.55万
  • 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
  • 批准号:
    2599490
  • 财政年份:
    2021
  • 资助金额:
    $ 22.55万
  • 项目类别:
    Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10358855
  • 财政年份:
    2021
  • 资助金额:
    $ 22.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了